Document is current
Any future updates will be listed below
-
Authors
Wulczynski, Mark
Constante, Marco
Galipeau, Heather J.
Blom, JedidJah
Rueda, Gaston H.
El-Chaar, Nancy https://orcid.org/0009-0002-2573-9509
Superdock, Dorothy K. https://orcid.org/0000-0001-5348-3307
Jiang, Sharon
David, Lawrence A. https://orcid.org/0000-0002-3570-4767
Murray, Joseph A.
Surette, Michael G. https://orcid.org/0000-0003-0086-4995
Armstrong, David https://orcid.org/0000-0003-2487-1479
Pinto-Sanchez, Maria Ines
Bercik, Premysl https://orcid.org/0000-0001-8707-1781
Caminero, Alberto https://orcid.org/0000-0001-9555-7167
Verdu, Elena F. https://orcid.org/0000-0001-6346-2665
- License Information
-
More Information
Article History
Received: 1 May 2025
Accepted: 27 February 2026
First Online: 31 March 2026
Competing interests
: The authors declare the following competing interests: M.W. is a co-chair for the International Society for the Study of Celiac Disease Young Investigator committee. H.J.G. is a member of the Research Committee for the Society for the Study of Celiac Disease. L.A.D. consults for City of Hope on dietary assessment technology and is a member of the Global Grants for Gut Health Colloquium (Nature Portfolio/Yakult). D.A. is the Co-founder and Chief Innovation Officer of A.I. VALI Inc.; a member of the advisory board for Cinclus Pharma, Crohn’s and Colitis Canada, Phathom Pharmaceuticals, and Sanofi; a board member of the Canadian Digestive Health Foundation, International Working Group for the Classification of Oesophagitis; has received speaker’s fees from Ferring and Takeda; and research funding from Nestle Health Sciences, Weston Family Foundation, INOVAIT, and Digital Health Innovation Fund. J.A.M. reports grants from: National Institutes of Health, Department of Defence, Takeda Pharmaceutical, Sanofi, Oberkotter Foundation, and 9 Meters Biopharma; Teva; and Consultancy Fees from Immunic Therapeutics, Chugai Pharma, Alimentiv, Vaccitech PLC, Dr Falk, Sanofi Aventis, FCPM III, Forte Biosciences, Zag Bio, LoopLab Bio, AnaptysBio Inc., Kerna Ventures, Catalys Pacific LLC, GI Reviewers LLC; and has received Royalties from Evelo Biosciences. J.A.M. also shares in Entero Healthcare and Minnesota Medical Technologies. M.I.P.S. received funding from Takeda, ProventionBio, and Celiac Canada, and is a member of Celiac Canada’s professional advisory board. E.F.V. is the secretary of the International Society for the Study of Celiac Disease and a member of the Advisory Board of the Biocodex Foundation. M.C., J.B., G.H.R., N.E., D.K.S., S.J., M.G.S., P.B., and A.C. declare no competing interests.
